PillRx only · Injection, Solution · Intravenous
Clindamycin In 5 Percent Dextrose
Clindamycin
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
2.5K
Rx · 2026 Q1
123K
Units dispensed
-27%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Sandoz Inc | unknown | 3 | SUPPLYING |
| Civica, Inc. | unknown | 2 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 21, 2023SHORTAGEDrug shortage: Clindamycin Phosphate Injection (Sandoz Inc.)
Clindamycin Phosphate Injection — reported in shortage by Sandoz Inc.. Therapeutic category: Anti-Infective.